EUHEARING
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

EUHEARING Trademark

Serial Number: 99163934

EUHEARING is a trademark filed by Shanghai Euhearing Therapeutics Co., Ltd. on April 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Shanghai Euhearing Therapeutics Co., Ltd. (4 trademarks)

Room 1412, Asia-Pacific Enterprise Building, No. 333
Shanghai 200030 , CN

Entity Type: 16

Trademark Details

Filing Date

April 30, 2025

Registration Date

Not Registered

Published for Opposition

February 17, 2026

Goods & Services

In-ear monitors for medical purposes; Ear trumpet; In-ear medicine delivery devices, namely, syringes and needles; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments for surgery of the nerve associated with the auditory pathway; Surgical and medical apparatus and instruments for use in otologic microsurgery; Surgical and medical apparatus and instruments for use in general surgery; Injection syringes (syringe barrels); Injection needles; Attachments for medical injection devices to aid in controlling the depth of the injections; Attachments for medical injection devices to aid in stabilizing flow during injection of pharmaceuticals; Syringes for injections; Injection instruments with needles; Injection device for pharmaceuticals

Liquid medicinal preparations for tinnitus treatment; Medicines for improvement of deafness gene; Medicinal preparations for treatment of deafness; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for gene therapy for the treatment of deafness; medicinal preparations for improving hearing loss; Medicinal infusions for treating hearing loss

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing laboratory research services in the field of deafness gene expression; Development of gene-based medicines; Gene therapy research; Research in the field of gene editing technology; Scientific research in the nature of conducting clinical trials for others in the field of deafness treatment; Development of pharmaceuticals for cell and gene therapies; Laboratory research in the field of gene expression; Research and development services in the field of gene expression systems; Testing of pharmaceuticals for cell and gene therapies.

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 14, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 19, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 9, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Apr 30, 2025 MAFR
NEW APPLICATION ENTERED
Apr 30, 2025 NWAP